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Volume 58, Number 6 Abstracts 1723to simple “go home and walk” advice, when supervised exercise training
is unavailable or impractical.
The Cost-effectiveness of Supervised Exercise for the Treatment of
Intermittent Claudication
Bermingham S.L., Sparrow K., Mullis R., Fox M., Shearman C.,
Bradbury A., Michaels J. Eur J Vasc Endovasc Surg 2013;46:707-14.
Background: Supervised exercise (SE) is thought to result in
improvements in walking distance and quality of life compared with unsu-
pervised exercise (USE) in people with intermittent claudication. However,
the cost-effectiveness of SE is unclear. As a result, many patients are
currently unable to access supervised programmes.
Methods: We searched MEDLINE, Embase, Cochrane, and Cinahl
databases to identify randomised controlled trials comparing USE
with SE in adults with intermittent claudication. A Markov model
was developed to estimate costs and quality adjusted life years (QALYs)
from an NHS and personal social services perspective. Quality of life
was obtained from the included clinical trials. Resource use was
modelled on current programmes and unit costs were based on pub-
lished sources.
Results: Depending on estimated rates of compliance, SE was cost-
effective in over 75% of model simulations, with an incremental cost-effec-
tiveness ratio of £711 to £1,608 per QALY gained. The model was sensitive
to long-term effects of exercise on cardiovascular risk and quality of life.
Conclusions: SE is more cost-effective than USE for the treatment of
people with intermittent claudication. Supervised programmes should be
made widely available and offered as a ﬁrst line treatment to people with
intermittent claudication.Vascular Training Proﬁles across Europe
Avgerinos E.D., on behalf of the European Vascular Surgeons in Training
(EVST) Writing Committee Eur J Vasc Endovasc Surg 2013;46:719-26.
Background: The European Vascular Surgeons in Training (EVST)
were appointed by the European Society for Vascular Surgery to review
the current status and developments regarding training and certiﬁcation in
vascular surgery (VS) across Europe.
Methods: An e-mail-based survey was distributed to EVST represen-
tatives in 33 countries. The questionnaire examined the current structure of
vascular surgery training and certiﬁcation (monospecialty, subspecialty, no
specialty), as well as the evolving revisions of national curricula. Question-
naires were returned from 31 countries, two of which implement two
training models.
Results: Vascular surgery (VS) as a monospecialty is the leading
training model in 18 out of 31 countries, nine countries follow the subspe-
cialty model, and six countries have no accredited vascular programs. The
mean duration of dedicated VS training in monospecialty is signiﬁcantly
longer compared with subspecialty (3.8 vs 2.9 years, P = .036) or no
specialty models (3.8 vs 1 years, P < .001). 83% of countries implementing
an independent certiﬁcation have recently updated their training curric-
ulum; the respective rates for countries implementing a subspecialty or no
specialty model are 56% and 17%. Among countries that offer VS certiﬁca-
tion, the endovascular logbook is mandatory in 78%, quality control of
training centers or trainers is implemented in 62%, and training centers
are reported as heterogeneous in 46%. The Working Time Directive is fol-
lowed by vascular trainees in 10/24 EU countries.
Conclusions: The results of this survey represent the most updated
detailed record of the European training proﬁles in VS and document the
diversity of vascular training across Europe.
